[시장보고서]멀티플렉스 어세이 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

멀티플렉스 어세이 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Multiplex Assays Market (Product: Instruments, Consumables, and Software; and Technology: Multiplex RT-PCR, Flow Cytometry, Fluorescence, and Luminescence) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

상품코드 : 1459787

리서치사 : Transparency Market Research

발행일 : 2024년 02월

페이지 정보 : 영문 333 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,366,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,698,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,029,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

멀티플렉스 어세이 시장 - 조사 범위

TMR의 조사 보고서 "세계 멀티플렉스 어세이 시장"은 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 2023년을 기준 연도로, 2031년을 예측 연도로 삼고 있습니다. 2017년부터 2031년까지 세계 멀티플렉스 어세이 시장의 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 세계 멀티플렉스 어세이 시장의 복합 연간 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 멀티플렉스 어세이 시장을 파악했습니다, 멀티플렉스 어세이 시장을 파악했습니다.

시장 현황
2022년 시장 가치	32억 달러
2031년 시장 가치	59억 달러
CAGR	6.9%

이 보고서는 세계 멀티플렉스 어세이 시장의 경쟁 환경을 조사했습니다. 세계 멀티플렉스 어세이 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 시장 개발, SWOT는 이 보고서에 소개된 세계 멀티플렉스 어세이 시장의 기업 속성입니다.

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 용도별, 2017-2031년
- 연구개발
  - Drug Discovery & Research
  - 바이오 마커 연구 및 응용
- 진단
  - 감염증
  - 자가면역질환
  - 암
  - 심혈관질환
  - 신경내분비질환
  - 기타
- 기타
시장의 매력 : 용도별

제10장 세계 시장 분석과 예측 : 최종사용자별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2017년-2031년
- 바이오테크놀러지 및 바이오의약품 기업
- 학술 및 연구센터
- 진단센터
- 병원
- 기타
시장의 매력 : 최종사용자별

제11장 세계 시장 분석과 예측 : 지역별

주요 조사 결과
시장 매출 예측 : 지역별, 2017년-2031년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
시장의 매력 : 지역별

제12장 북미 시장 분석과 예측

제13장 유럽 시장 분석과 예측

제14장 아시아태평양 시장 분석과 예측

제15장 라틴아메리카 시장 분석과 예측

제16장 중동 및 아프리카 시장 분석과 예측

제17장 경쟁 구도

시장 경쟁 매트릭스(기업 Tier별·기업 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
- DiaSorin S.p.A.
- Thermo Fisher Scientific, Inc.
- Seegene, Inc.
- Meso Scale Diagnostics, LLC
- Abcam Limited
- QIAGEN
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Quansys Biosciences
- Illumina, Inc.

LSH

영문 목차

영문목차

Multiplex Assays Market - Scope of Report

TMR's report on the global multiplex assayss market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global multiplex assayss market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global multiplex assayss market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the multiplex assayss market.

Market Snapshot
Market Value in 2022	US$ 3.2 Bn
Market Value in 2031	US$ 5.9 Bn
CAGR	6.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global multiplex assayss market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global multiplex assayss market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global multiplex assayss market.

The report delves into the competitive landscape of the global multiplex assayss market. Key players operating in the global multiplex assayss market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global multiplex assayss market profiled in this report.

Key Questions Answered in Global multiplex assayss Market Report:

What is the sales/revenue generated by multiplex assayss across all regions during the forecast period?
What are the opportunities in the global multiplex assayss market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Multiplex Assays Market - Research Objectives and Research Approach

The comprehensive report on the global multiplex assayss market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global multiplex assayss market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global multiplex assayss market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Multiplex Assays Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Multiplex Assays Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Multiplex Assays Market Analysis and Forecast, by Product

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Instruments
- 6.3.2. Consumables
  - 6.3.2.1. Reagents & Kits
  - 6.3.2.2. Micropipettes & Microplates
  - 6.3.2.3. Others
- 6.3.3. Software
6.4. Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis and Forecast, by Technology

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017-2031
- 7.3.1. Multiplex RT-PCR
- 7.3.2. Flow Cytometry
- 7.3.3. Luminescence
- 7.3.4. Fluorescence
- 7.3.5. Others
- 7.3.6. Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis and Forecast, By Type

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Type, 2017-2031
- 8.3.1. Protein
  - 8.3.1.1. Planar
  - 8.3.1.2. Bead-based
- 8.3.2. Nucleic Acid
  - 8.3.2.1. Planar
  - 8.3.2.2. Bead-based
- 8.3.3. Cell
8.4. Market Attractiveness, By Type

9. Global Multiplex Assays Market Analysis and Forecast, by Application

9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017-2031
- 9.3.1. Research & Development
  - 9.3.1.1. Drug Discovery & Research
  - 9.3.1.2. Biomarker Research & Application
- 9.3.2. Diagnosis
  - 9.3.2.1. Infectious Diseases
  - 9.3.2.2. Autoimmune Diseases
  - 9.3.2.3. Cancer
  - 9.3.2.4. Cardiovascular Diseases
  - 9.3.2.5. Neuroendocrine Diseases
  - 9.3.2.6. Others
- 9.3.3. Others
9.4. Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis and Forecast, by End-user

10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Biotechnology & Biopharmaceutical Companies
- 10.3.2. Academic & Research Centers
- 10.3.3. Diagnostic Centers
- 10.3.4. Hospitals
- 10.3.5. Others
10.4. Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecast, by Region

11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017-2031
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region

12. North America Multiplex Assays Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Instruments & Software
- 12.2.2. Kits & Reagents
- 12.2.3. Services
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2017-2031
- 12.4.1. Conventional PCR
- 12.4.2. Singleplex PCR
- 12.4.3. Multiplex PCR
- 12.4.4. Real-time PCR
- 12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, By Type, 2017-2031
- 12.6.1. Protein
  - 12.6.1.1. Planar
  - 12.6.1.2. Bead-based
- 12.6.2. Nucleic Acid
  - 12.6.2.1. Planar
  - 12.6.2.2. Bead-based
- 12.6.3. Cell
12.7. Market Attractiveness, By Type
12.8. Market Value Forecast, by Application, 2017-2031
- 12.8.1. Companion Animal
- 12.8.2. Livestock Animal
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by End-user, 2017-2031
- 12.10.1. Biotechnology & Biopharmaceutical Companies
- 12.10.2. Academic & Research Centers
- 12.10.3. Diagnostic Centers
- 12.10.4. Hospitals
- 12.10.5. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.12.1. U.S.
- 12.12.2. Canada
12.13. Market Attractiveness Analysis
- 12.13.1. By Product
- 12.13.2. By Technology
- 12.13.3. By Type
- 12.13.4. By Application
- 12.13.5. By End-user
- 12.13.6. By Country

13. Europe Multiplex Assays Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Instruments
- 13.2.2. Consumables
  - 13.2.2.1. Reagents & Kits
  - 13.2.2.2. Micropipettes & Microplates
  - 13.2.2.3. Others
- 13.2.3. Software
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2017-2031
- 13.4.1. Multiplex RT-PCR
- 13.4.2. Flow Cytometry
- 13.4.3. Luminescence
- 13.4.4. Fluorescence
- 13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, By Type, 2017-2031
- 13.6.1. Protein
  - 13.6.1.1. Planar
  - 13.6.1.2. Bead-based
- 13.6.2. Nucleic Acid
  - 13.6.2.1. Planar
  - 13.6.2.2. Bead-based
- 13.6.3. Cell
13.7. Market Attractiveness, By Type
13.8. Market Value Forecast, by Application, 2017-2031
- 13.8.1. Research & Development
  - 13.8.1.1. Drug Discovery & Research
  - 13.8.1.2. Biomarker Research & Application
- 13.8.2. Diagnosis
  - 13.8.2.1. Infectious Diseases
  - 13.8.2.2. Autoimmune Diseases
  - 13.8.2.3. Cancer
  - 13.8.2.4. Cardiovascular Diseases
  - 13.8.2.5. Neuroendocrine Diseases
  - 13.8.2.6. Others
- 13.8.3. Others
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by End-user, 2017-2031
- 13.10.1. Biotechnology & Biopharmaceutical Companies
- 13.10.2. Academic & Research Centers
- 13.10.3. Diagnostic Centers
- 13.10.4. Hospitals
- 13.10.5. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.12.1. Germany
- 13.12.2. U.K.
- 13.12.3. France
- 13.12.4. Italy
- 13.12.5. Spain
- 13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
- 13.13.1. By Product
- 13.13.2. By Technology
- 13.13.3. By Type
- 13.13.4. By Application
- 13.13.5. By End-user
- 13.13.6. By Country/Sub-region

14. Asia Pacific Multiplex Assays Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Instruments
- 14.2.2. Consumables
  - 14.2.2.1. Reagents & Kits
  - 14.2.2.2. Micropipettes & Microplates
  - 14.2.2.3. Others
- 14.2.3. Software
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2017-2031
- 14.4.1. Multiplex RT-PCR
- 14.4.2. Flow Cytometry
- 14.4.3. Luminescence
- 14.4.4. Fluorescence
- 14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, By Type, 2017-2031
- 14.6.1. Protein
  - 14.6.1.1. Planar
  - 14.6.1.2. Bead-based
- 14.6.2. Nucleic Acid
  - 14.6.2.1. Planar
  - 14.6.2.2. Bead-based
- 14.6.3. Cell
14.7. Market Attractiveness, By Type
14.8. Market Value Forecast, by Application, 2017-2031
- 14.8.1. Research & Development
  - 14.8.1.1. Drug Discovery & Research
  - 14.8.1.2. Biomarker Research & Application
- 14.8.2. Diagnosis
  - 14.8.2.1. Infectious Diseases
  - 14.8.2.2. Autoimmune Diseases
  - 14.8.2.3. Cancer
  - 14.8.2.4. Cardiovascular Diseases
  - 14.8.2.5. Neuroendocrine Diseases
  - 14.8.2.6. Others
- 14.8.3. Others
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by End-user, 2017-2031
- 14.10.1. Biotechnology & Biopharmaceutical Companies
- 14.10.2. Academic & Research Centers
- 14.10.3. Diagnostic Centers
- 14.10.4. Hospitals
- 14.10.5. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.12.1. China
- 14.12.2. Japan
- 14.12.3. India
- 14.12.4. Australia & New Zealand
- 14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
- 14.13.1. By Product
- 14.13.2. By Technology
- 14.13.3. By Type
- 14.13.4. By Application
- 14.13.5. By End-user
- 14.13.6. By Country/Sub-region

15. Latin America Multiplex Assays Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Instruments
- 15.2.2. Consumables
  - 15.2.2.1. Reagents & Kits
  - 15.2.2.2. Micropipettes & Microplates
  - 15.2.2.3. Others
- 15.2.3. Software
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technology, 2017-2031
- 15.4.1. Multiplex RT-PCR
- 15.4.2. Flow Cytometry
- 15.4.3. Luminescence
- 15.4.4. Fluorescence
- 15.4.5. Others
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, By Type, 2017-2031
- 15.6.1. Protein
  - 15.6.1.1. Planar
  - 15.6.1.2. Bead-based
- 15.6.2. Nucleic Acid
  - 15.6.2.1. Planar
  - 15.6.2.2. Bead-based
- 15.6.3. Cell
15.7. Market Attractiveness, By Type
15.8. Market Value Forecast, by Application, 2017-2031
- 15.8.1. Research & Development
  - 15.8.1.1. Drug Discovery & Research
  - 15.8.1.2. Biomarker Research & Application
- 15.8.2. Diagnosis
  - 15.8.2.1. Infectious Diseases
  - 15.8.2.2. Autoimmune Diseases
  - 15.8.2.3. Cancer
  - 15.8.2.4. Cardiovascular Diseases
  - 15.8.2.5. Neuroendocrine Diseases
  - 15.8.2.6. Others
- 15.8.3. Others
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by End-user, 2017-2031
- 15.10.1. Biotechnology & Biopharmaceutical Companies
- 15.10.2. Academic & Research Centers
- 15.10.3. Diagnostic Centers
- 15.10.4. Hospitals
- 15.10.5. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.12.1. Brazil
- 15.12.2. Mexico
- 15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
- 15.13.1. By Product
- 15.13.2. By Technology
- 15.13.3. By Type
- 15.13.4. By Application
- 15.13.5. By End-user
- 15.13.6. By Country/Sub-region

16. Middle East & Africa Multiplex Assays Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2017-2031
- 16.2.1. Instruments
- 16.2.2. Consumables
  - 16.2.2.1. Reagents & Kits
  - 16.2.2.2. Micropipettes & Microplates
  - 16.2.2.3. Others
- 16.2.3. Software
16.3. Market Attractiveness, by Product
16.4. Market Value Forecast, by Technology, 2017-2031
- 16.4.1. Multiplex RT-PCR
- 16.4.2. Flow Cytometry
- 16.4.3. Luminescence
- 16.4.4. Fluorescence
- 16.4.5. Others
16.5. Market Attractiveness, by Technology
16.6. Market Value Forecast, By Type, 2017-2031
- 16.6.1. Protein
  - 16.6.1.1. Planar
  - 16.6.1.2. Bead-based
- 16.6.2. Nucleic Acid
  - 16.6.2.1. Planar
  - 16.6.2.2. Bead-based
- 16.6.3. Cell
16.7. Market Attractiveness, By Type
16.8. Market Value Forecast, by Application, 2017-2031
- 16.8.1. Research & Development
  - 16.8.1.1. Drug Discovery & Research
  - 16.8.1.2. Biomarker Research & Application
- 16.8.2. Diagnosis
  - 16.8.2.1. Infectious Diseases
  - 16.8.2.2. Autoimmune Diseases
  - 16.8.2.3. Cancer
  - 16.8.2.4. Cardiovascular Diseases
  - 16.8.2.5. Neuroendocrine Diseases
  - 16.8.2.6. Others
- 16.8.3. Others
16.9. Market Attractiveness, by Application
16.10. Market Value Forecast, by End-user, 2017-2031
- 16.10.1. Biotechnology & Biopharmaceutical Companies
- 16.10.2. Academic & Research Centers
- 16.10.3. Diagnostic Centers
- 16.10.4. Hospitals
- 16.10.5. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.12.1. GCC Countries
- 16.12.2. South Africa
- 16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
- 16.13.1. By Product
- 16.13.2. By Technology
- 16.13.3. By Type
- 16.13.4. By Application
- 16.13.5. By End-user
- 16.13.6. By Country/Sub-region

17. Competition Landscape

17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
- 17.3.1. DiaSorin S.p.A.
  - 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.1.2. Product Portfolio
  - 17.3.1.3. Financial Overview
  - 17.3.1.4. SWOT Analysis
  - 17.3.1.5. Strategic Overview
- 17.3.2. Thermo Fisher Scientific, Inc.
  - 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.2.2. Product Portfolio
  - 17.3.2.3. Financial Overview
  - 17.3.2.4. SWOT Analysis
  - 17.3.2.5. Strategic Overview
- 17.3.3. Seegene, Inc.
  - 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.3.2. Product Portfolio
  - 17.3.3.3. Financial Overview
  - 17.3.3.4. SWOT Analysis
  - 17.3.3.5. Strategic Overview
- 17.3.4. Meso Scale Diagnostics, LLC
  - 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.4.2. Product Portfolio
  - 17.3.4.3. Financial Overview
  - 17.3.4.4. SWOT Analysis
  - 17.3.4.5. Strategic Overview
- 17.3.5. Abcam Limited
  - 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.5.2. Product Portfolio
  - 17.3.5.3. Financial Overview
  - 17.3.5.4. SWOT Analysis
  - 17.3.5.5. Strategic Overview
- 17.3.6. QIAGEN
  - 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.6.2. Product Portfolio
  - 17.3.6.3. Financial Overview
  - 17.3.6.4. SWOT Analysis
  - 17.3.6.5. Strategic Overview
- 17.3.7. Bio-Rad Laboratories, Inc.
  - 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.7.2. Product Portfolio
  - 17.3.7.3. Financial Overview
  - 17.3.7.4. SWOT Analysis
  - 17.3.7.5. Strategic Overview
- 17.3.8. Merck KGaA
  - 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.8.2. Product Portfolio
  - 17.3.8.3. Financial Overview
  - 17.3.8.4. SWOT Analysis
  - 17.3.8.5. Strategic Overview
- 17.3.9. Quansys Biosciences
  - 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.9.2. Product Portfolio
  - 17.3.9.3. Financial Overview
  - 17.3.9.4. SWOT Analysis
  - 17.3.9.5. Strategic Overview
- 17.3.10. Illumina, Inc.
  - 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.10.2. Product Portfolio
  - 17.3.10.3. Financial Overview
  - 17.3.10.4. SWOT Analysis
  - 17.3.10.5. Strategic Overview